Structure and function of the corneal endothelium in diabetes mellitus type I and type II

Archives of Ophthalmology

Volumn 114, Issue 1, 1996, Pages 9-14

  Larsson, Lill Inger ^a,b   Bourne, William M ^a   Pach, John M ^a   Brubaker, Richard F ^a  

^a MAYO CLINIC   (United States)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AGING; ARTICLE; AUTOFLUORESCENCE; BLOOD GLUCOSE MONITORING; CONTROLLED STUDY; CORNEA ENDOTHELIUM; CORNEA PERMEABILITY; CORNEA THICKNESS; DIABETIC RETINOPATHY; FLUOROPHOTOMETRY; HUMAN; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

EID: 0030027715     PISSN: 00039950     EISSN: None     Source Type: Journal    
DOI: 10.1001/archopht.1996.01100130007001     Document Type: Article

References (39)

1. Perry HD, Foulks GN, Thoft RA, Tolentino FI Corneal complications after closed vitrectomy through pars plana. Arch Ophthalmol. 1978;96:1401-1403.
2. Michels RG, Ryan SJ. Results and complications of 100 consecutive cases of pars plana vitrectomy Am J Ophthalmol. 1975;80:24-36.
3. Foulks GN, Thoft RA, Perry HD, Tolentino FI. Factors related to corneal epithelial complications after closed vitrectomy in diabetics. Arch Ophthalmol. 1979; 97:1076-1078.
4. Göbbels M, Spitznas M, Oldendoerp J. Impairment of corneal epithelial barrier function in diabetics. Graefes Arch Clin Exp Ophthalmol. 1989;227:142-144.
5. Stolwijk TR, van Best JA, Boot JP, Lemkes HHPJ, Oosterhuis JA Corneal epithelial barrier function after oxybuprocaine provocation in diabetics. Invest Ophthalmol Vis Sci. 1990;31:436-439.
6. Olsen T, Busted N, Schmitz O. Corneal thickness in diabetes mellitus Lancet 1980;1:883.
7. Busted N, Olsen T, Schmitz O Clinical observations on the corneal thickness and the corneal endothelium in diabetes mellitus. Br J Ophthalmol. 1981;65: 687-690.
8. Herse P, Hooker B. Corneal edema recovery dynamics in diabetes: is the alloxan induced rabbit a useful model? Invest Ophthalmol Vis Sci 1994;35:310-313.
9. Weston BC, Bourne WM, Polse KA, Hodge DO Corneal hydration control in diabetes mellitus. Invest Ophthalmol Vis Sci. 1995;36:586-595.
10. Schultz RO, Matsuda M, Yee HW, Edelhauser HF, Schultz KJ Corneal endothelial changes in type I and type II diabetes mellitus. Am J Ophthalmol. 1984; 98:401-410.
11. Keoleran GM, Pach JM, Hodge DO, Trocme SD, Bourne WM. Structural and functional studies of the corneal endothelium in diabetes mellitus Am J Ophthalmol. 1992;113.64-70
12. Hoi M, Nakamura T, Mizobe K, Kodama Y, Nakagawa N, Itoi M. Specular microscopic studies of the corneal endothelium of Japanese diabetics. Cornea. 1989;8:2-6.
13. Matsuda M, Ohguro N, Ishimoto I, Fukuda M Relationship of corneal endothelial morphology to diabetic retinopathy, duration of diabetes and glycemic control. Jpn J Ophthalmol. 1990;34 53-56.
14. Yee RW, Matsuda M, Kern TS, Engerman RL Edelhauser HF. Corneal endothelial changes in diabetic dogs Curr Eye Res. 1985;4:759-766.
15. Rao GN, Shaw EL, Arthur EJ, Aquavella JV Endothelial cell morphology and corneal deturgescence. Ann Ophthalmol 1979;11:885-899.
16. Bourne WM, Brubaker RF, O'Fallon WM. Use of air to decrease endothelial cell loss during intraocular lens implantation Arch Ophthalmol. 1979,97:1473-1475.
17. Carlson KH, Bourne WM The clinical measurement of endothelial permeability. Cornea. 1988;7:183-189.
18. Lass JH, Spurney RV, Dutt RM, et al. A morphologic and fluorophotometric analysis of the corneal endothelium in type I diabetes mellitus and cystic fibrosis. Am J Ophthalmol. 1985;100:783-788.
19. Watsky MA, McDermott ML, Edelhauser HF. In vitro corneal endothelial permeability in rabbit and human: the effects of age, cataract surgery and diabetes. Exp Eye Res. 1989,49 751-767.
20. Ederer F. Shall we count numbers of eyes or numbers of subjects? Arch Ophthalmol 1973;89:1-2.
21. Rosner B Statistical methods in ophthalmology: an adjustment for the intraclass correlation between eyes. Biometrics. 1982,38:105-114.
22. Ray WA, O'Day DM. Statistical analysis of multi-eye data in ophthalmic research. Invest Opthalmol Vis Sci. 1985;26:1186-1188.
23. Katz J. Two eyes or one? The data analyst's dilemma. Ophthalmic Surg 1988; 19.585-589.
24. McLaren JW, Brubaker RF. A two-dimensional scanning ocular fluorophotometer. Invest Ophthalmol Vis Sci. 1985;26.144-152.
25. Diabetic Retinopathy Study Research Group. Report No. 7: a modification of the Airlie House classification of diabetic retinopathy. Invest Ophthalmol Vis Sci. 1981;21:210-226.
26. Early Treatment Diabetic Retinopathy Study Research Group. Manual of Operations. Springfield, Va. US Dept of Commerce, National Technical Information Service; 1985. Accession No. PB85 223006/AS.
27. Bourne WM, Enoch JM. Some optical principles of the clinical specular microscope. Invest Ophthalmol Vis Sci. 1976;15:29-32.
28. Carlson KH, Bourne WM, McLaren JW, Brubaker RF. Variations in human corneal endothelial cell morphology and permeability to fluorescein with age. Exp Eye Res. 1988;47:27-41
29. Baratz KH, Trocme SO, Bourne WM. Cold-induced corneal edema in patients with trigeminal nerve dysfunction. Am J Ophthalmol. 1991;112:548-556.
30. Ota Y, Mishima S, Maurice DM. Endothelial permeability of the living cornea to fluorescein. Invest Ophthalmol. 1974;13:945-949
31. Chang S-W, Hu F-R. Changes in corneal autofluorescence and corneal epithelial barrier function with aging. Cornea. 1993;12 493-499.
32. Stolwijk TR, van Best JA, Boot JP, Oosterhuis JO. Corneal autofluorescence in diabetic and penetrating keratoplasty patients as measured by fluorophotometry. Exp Eye Res. 1990;51:403-409.
33. Stolwijk TR, van Best JA, Oosterhuis JA, Swarr W. Corneal autofluorescence: an indicator of diabetic retinopathy. Invest Ophthalmol Vis Sci. 1992;33.92-97.
34. Kuppens E, Stolwijk T, van Best J, de Keizer R. Topical timolol, corneal epithelial permeability and autofluorescence in glaucoma by fluorophotometry Graefes Arch Clin Exp Ophthalmol. 1994,232:215-220.
35. Boets EPM, van Best JA. Corneal autofluorescence and epithelial barrier function Cornea. 1994;13:373-374.
36. Larsen M, Kjer B, Bendtson I, Dalgaard P, Lund-Andersen H. Lens fluorescence in relation to metabolic control of insulin-dependent diabetes mellitus. Arch Ophthalmol. 1989;107:59-62.
37. Laing RA, Fischbarg J, Chance B. Noninvasive measurements of pyridine nucleotide fluorescence from the cornea. Invest Ophthalmol Vis Sci. 1980;19:96-102
38. Masters BR. In vivo redox fluorometry. In: Masters BR, ed. Noninvasive Diagnostic Techniques in Ophthalmology. New York, NY: Springer-Verlag Inc; 1990:223-247.
39. Master BR, Falk S, Chance B. In vivo flavoprotein redox measurements of rabbit corneal normoxic-anoxic transitions. Curr Eye Res. 1981;1:623-627.